Registered entities
Pelage Pharmaceuticals, Inc.
Reg. No. 824990957United States
Innovation
5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 392 times.
| Year | Filings |
|---|---|
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 4.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record; lead investors include Google Ventures, Arch Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Bank & private debt | 1 | 20% |
Recent activity
11 Jun 2026
Event
BIO2026
7 Apr 2026
Event
CMOSummit360 panel discussion
27 Mar 2026
Product launch
PP405